Vivanza Biosciences shareholders approved all nine resolutions at the company’s 44th Annual General Meeting held on September 11, 2026, with voting results showing near-unanimous support for key governance and financial authority measures.

The meeting was conducted via video conferencing in compliance with Ministry of Corporate Affairs circulars. Remote e-voting was open from September 8 to September 10, 2026, through National Securities Depository Limited (NSDL). No votes were cast during the live AGM session, as all participation occurred via remote e-voting.

Voting Results by Resolution

The scrutinizer’s report, submitted by Chintan K. Patel, detailed the vote counts for each resolution. All proposals passed comfortably, with several receiving 100% of valid votes cast.

Key Resolutions Approved

Shareholders voted on several ordinary and special business items. The primary focus included governance updates and financial authority expansions.

• Financial Statements: The adoption of FY26 audited standalone and consolidated financial statements received unanimous support (100%).
• Director Appointments: Mr. Jayendra Mehta was re-appointed as Director with 99.99% support. Mr. H.A. Parikh was regularized as a Non-Executive Non-Independent Director with 100% support.
• Borrowing & Investments: Shareholders approved an increase in borrowing limits under Section 180(1)(C) with 99.99% support. Authority for investments, loans, and guarantees under Section 186 also passed with 99.99% support.
• Governance Documents: New Memorandum and Articles of Association were adopted with 100% approval.

Management Commentary

Mr. Jainil Bhatt, Chief Financial Officer, apprised members of the company’s financial performance and future prospects. No questions or queries were raised by shareholders during the session.

The Chairman and Managing Director, Mr. Mehta J.A., presided over the meeting. Other attendees included Independent Directors Mr. Hitesh Rijwani and Ms. Reena Kumari, along with Statutory Auditor Mr. Shivam Soni and Secretarial Auditor Mr. Chintan Patel.

Voting Process and Corrigendum

Mr. Chintan K. Patel served as the Scrutinizer for the voting process. The combined results were disseminated to stock exchanges within 48 hours of the meeting's conclusion.

The company issued a corrigendum on September 12, 2026, clarifying that the e-voting service provider was National Securities Depository Limited (NSDL), not Central Depository Services (India) Limited (CDSL) as erroneously stated in the initial report. The voting percentages and resolution outcomes remain unchanged.

Vivanza Biosciences Limited has scheduled its 44th Annual General Meeting (AGM) for Friday, September 11, 2026, at 3:30 pm. The meeting will be conducted through Video Conference or Other Audio-Visual Means (VC/OAVM), with the deemed venue fixed at the company’s registered office in Ahmedabad. This follows a board meeting held on August 17, 2026, where directors approved the convening of the AGM and proposed amendments to constitutional documents.

Financial Results for FY26

The primary ordinary business item involves the adoption of the audited standalone and consolidated financial statements for the financial year ended March 31, 2026. During FY26, the company reported a significant turnaround in profitability. Standalone revenue from operations rose to ₹11,234.04 lakh, up from ₹297.74 lakh in the previous year. The company posted a net profit of ₹37.50 lakh after tax, compared to a net loss of ₹69.51 lakh in FY25. Consolidated revenue stood at ₹11,602.21 lakh, with consolidated profit after tax at ₹39.44 lakh.

The Board did not recommend any dividend for the year under review. Reserves and surplus stood at ₹39.54 lakh as of March 31, 2026, compared to ₹2.04 lakh at the beginning of the year.

Board Appointments and Reappointments

Shareholders will consider the reappointment of Mr. Jayendra A. Mehta as Managing Director, who retires by rotation at this AGM and is eligible for reappointment. Additionally, the meeting will approve the regularization of Mr. H.A. Parikh as a Non-Executive Non-Independent Director. Mr. Parikh was initially appointed as an Additional Director with effect from June 18, 2026, and holds office until this AGM.

Other board changes disclosed include the appointment of Mr. Sarang B. Pathak as a Non-Executive Non-Independent Director effective August 30, 2025, and Mr. Hitesh Rijwani as an Independent Director effective May 12, 2025. Ms. Rina Kumari continues as an Independent Director.

Special Resolutions and Corporate Governance

The AGM will seek shareholder approval for several special resolutions:

• Related Party Transactions: Approval for material related party transactions during FY27, with an aggregate limit of up to ₹100 crore.
• Borrowing Limits: Increase in borrowing limits under Section 180(1)(c) of the Companies Act, 2013, allowing the board to borrow sums exceeding the aggregate of paid-up share capital, free reserves, and securities premium, up to ₹100 crore.
• Investments and Guarantees: Approval under Section 186 for investments, loans, guarantees, or securities up to ₹50 crore.
• Loans to Interested Entities: Approval under Section 185 for loans or financial assistance to entities in which directors are interested, up to ₹50 crore.
• Constitutional Documents: Adoption of new Memorandum of Association (MoA) and Articles of Association (AoA) aligned with the Companies Act, 2013.

E-Voting and Meeting Logistics

The cut-off date for determining member eligibility to attend and vote is September 4, 2026. Remote e-voting will be available from September 8, 2026, at 9:00 am to September 10, 2026, at 5:00 pm, through the National Securities Depository Limited (NSDL) e-voting system. Mr. Chintan K. Patel, a practicing company secretary, has been appointed as the scrutinizer to oversee the e-voting process. Participation in the VC/OAVM meeting is limited to 1,000 members on a first-come, first-served basis, excluding large shareholders holding 2% or more, promoters, institutional investors, and key managerial personnel.